Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Clinical Imbalances

Hormonal

Immune and inflammation

Laboratory Testing

Blood

Text Availability

Abstract

349

Full text

284

Free full text

160

Publication Types

Journal Article

352

Randomized Controlled Trial

149

Research Support, Non-U.S. Gov't

141

Multicenter Study

139

Comparative Study

Review

Clinical Trial

Observational Study

Clinical Trial, Phase II

Clinical Trial, Phase I

Clinical Trial, Phase III

Meta-Analysis

Systematic Review

Research Support, N.I.H., Extramural

Network Meta-Analysis

Equivalence Trial

Case Reports

Clinical Trial, Phase IV

Clinical Trial Protocol

Letter

Research Support, U.S. Gov't, P.H.S.

Pragmatic Clinical Trial

Controlled Clinical Trial

Editorial

Publication Year

From

Quick links

Individual year

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2002

2001

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Everolimus""[mesh_terms]

355 Results

Searching titles within these results

Platinum chromium everolimus-eluting stents for the treatment of (complex) coronary artery disease; from SYNERGY™ to the MEGATRON™.

Johan Bennett, Keir McCutcheon, Gianluca Castaldi, Pascal Frederiks

Expert review of medical devices 2024;21(7):601-611

Full Text

Abstract

Incidence and risk of hepatic toxicities with PD-1 inhibitors in cancer patients: a meta-analysis.

Xi Zhang, Yuge Ran, Kunjie Wang, Yuanxue Zhu, Jinghua Li

Drug design, development and therapy 2017;10():3153-3161

Free Full Text

Abstract

Long-Term Everolimus Treatment in Individuals With Tuberous Sclerosis Complex: A Review of the Current Literature.

Lily H Tran, Mary L Zupanc

Pediatric neurology 2016;53(1):23-30

Full Text

Abstract

mTOR Inhibition and Cardiovascular Diseases: Dyslipidemia and Atherosclerosis.

Ammar Kurdi, Wim Martinet, Guido R Y De Meyer

Transplantation 2018;102(2S Suppl 1):S44-S46

Full Text

Abstract

Composite outcomes in 2.25-mm drug eluting stents: a systematic review.

Justin Z Lee, Nirmal Singh, Gilbert Ortega, See Wei Low, Uday Kanakadandi, F David Fortuin, Tom Lassar, Kwan S Lee

Cardiovascular revascularization medicine : including molecular interventions 2016;16(4):237-42

Full Text

Abstract

Everolimus Personalized Therapy: Second Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.

Ron van Schaik, Brenda de Winter, Ofelia Noceti, Tomasz Pawinski, Christoph Seger, Satohiro Masuda, Olga Millan, Loralie J Langman, Nuria Lloberas, Dirk Jan A R Moes, Mercè Brunet, Michael Oellerich, Maria Shipkova, Eberhard Wieland, Jean-Baptiste Woillard, Laure Elens, Florian Lemaitre, Markus J Barten, Raman Venkataramanan, Pierre Marquet, Stein Bergan, Teun van Gelder, Maja-Theresa Dieterlen, Tomoyuki Mizuno, Smita Pattanaik, Sander Vinks, Kirsten Bornemann-Kolatzki, Taihei Ito, Kamisha Johnson-Davis, Pawel K Kunicki, Roland Lawson, Phil Walson

Therapeutic drug monitoring 2025;47(1):4-31

Full Text

Abstract

Clinical results of the EVESOR trial, a multiparameter phase I trial of everolimus and sorafenib combination in solid tumors.

Romain Varnier, Alicja Puszkiel, Michel Tod, Sara Calattini, Lea Payen, Jonathan Lopez, Jérome Guitton, Vérane Schwiertz, Juliette Fontaine, Julien Peron, Denis Maillet, Sophie Tartas, Nathalie Bonnin, Olivier Colomban, Diane Augu-Denechere, Gilles Freyer, Benoit You

Cancer chemotherapy and pharmacology 2023;91(5):361-373

Full Text

Abstract

Tremor Induced by Cyclosporine, Tacrolimus, Sirolimus, or Everolimus: A Review of the Literature.

Aparna Wagle Shukla, Caroline Lunny, Omar Mahboob, Uzair Khalid, Malea Joyce, Nivedita Jha, Nandakumar Nagaraja, Ashutosh M Shukla

Drugs in R&D 2023;23(4):301-329

Free Full Text

Abstract

Mammalian target of rapamycin as a therapeutic target in leukemia.

Francis J Giles, Maher Albitar

Current molecular medicine 2006;5(7):653-61

Full Text

Abstract

Mechanisms of mammalian target of rapamycin inhibition in sarcoma: present and future.

Margaret von Mehren, Amy R MacKenzie

Expert review of anticancer therapy 2008;7(8):1145-54

Full Text

Abstract

A randomized exploratory trial of steroid avoidance in renal transplant patients treated with everolimus and low-dose cyclosporine.

Giuseppe Montagnino, Silvio Sandrini, Beniamino Iorio, Francesco Paolo Schena, Mario Carmellini, Paolo Rigotti, Maria Cossu, Paolo Altieri, Maurizio Salvadori, Sergio Stefoni, Giuseppe Corbetta, Claudio Ponticelli

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(2):707-14

Full Text

Abstract

Oral Care Evaluation to Prevent Oral Mucositis in Estrogen Receptor-Positive Metastatic Breast Cancer Patients Treated with Everolimus (Oral Care-BC): A Randomized Controlled Phase III Trial.

Naoki Niikura, Katsuhiko Nakatukasa, Takeshi Amemiya, Ken-Ichi Watanabe, Hironobu Hata, Yuichiro Kikawa, Naoki Taniike, Takashi Yamanaka, Sachiyo Mitsunaga, Kazuhiko Nakagami, Moriyasu Adachi, Naoto Kondo, Yasuyuki Shibuya, Naoki Hayashi, Mariko Naito, Kosuke Kashiwabara, Toshinari Yamashita, Masahiro Umeda, Hirofumi Mukai, Yoshihide Ota

The oncologist 2021;25(2):e223-e230

Free Full Text

Abstract

mTOR inhibitors and dyslipidemia in transplant recipients: a cause for concern?

Hallvard Holdaas, Luciano Potena, Faouzi Saliba

Transplantation reviews (Orlando, Fla.) 2016;29(2):93-102

Full Text

Abstract

Differential aspects between cobalt-chromium everolimus drug-eluting stent and Absorb everolimus bioresorbable vascular scaffold: from bench to clinical use.

Yohei Sotomi, Pannipa Suwannasom, Erhan Tenekecioglu, Hiroki Tateishi, Mohammad Abdelghani, Patrick W Serruys, Yoshinobu Onuma

Expert review of cardiovascular therapy 2016;13(10):1127-45

Full Text

Abstract

A role for everolimus in post-transplant encapsulating peritoneal sclerosis: first case report.

Rahul Sud, Lorraine Garry, Stephen Timothy Spicer, Richard D M Allen, Josette M Eris, Kate Wyburn, Deborah Verran, Caroline Louise Cooper, Steve Chadban

Nephrology (Carlton, Vic.) 2014;19 Suppl 1():27-30

Full Text

Abstract

Results: 1 – 15 / 355

Filters

Expert Opinion

Clinical Imbalances

Laboratory Testing

Text Availability

Publication Types

Publication Year

Results for ""Everolimus""[mesh_terms]

Platinum chromium everolimus-eluting stents for the treatment of (complex) coronary artery disease; from SYNERGY™ to the MEGATRON™.

Incidence and risk of hepatic toxicities with PD-1 inhibitors in cancer patients: a meta-analysis.

Long-Term Everolimus Treatment in Individuals With Tuberous Sclerosis Complex: A Review of the Current Literature.

mTOR Inhibition and Cardiovascular Diseases: Dyslipidemia and Atherosclerosis.

Composite outcomes in 2.25-mm drug eluting stents: a systematic review.

Everolimus Personalized Therapy: Second Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.

Clinical results of the EVESOR trial, a multiparameter phase I trial of everolimus and sorafenib combination in solid tumors.

Tremor Induced by Cyclosporine, Tacrolimus, Sirolimus, or Everolimus: A Review of the Literature.

Mammalian target of rapamycin as a therapeutic target in leukemia.

Mechanisms of mammalian target of rapamycin inhibition in sarcoma: present and future.

A randomized exploratory trial of steroid avoidance in renal transplant patients treated with everolimus and low-dose cyclosporine.

Oral Care Evaluation to Prevent Oral Mucositis in Estrogen Receptor-Positive Metastatic Breast Cancer Patients Treated with Everolimus (Oral Care-BC): A Randomized Controlled Phase III Trial.

mTOR inhibitors and dyslipidemia in transplant recipients: a cause for concern?

Differential aspects between cobalt-chromium everolimus drug-eluting stent and Absorb everolimus bioresorbable vascular scaffold: from bench to clinical use.

A role for everolimus in post-transplant encapsulating peritoneal sclerosis: first case report.

Results for
""Everolimus""[mesh_terms]